Recognition and processing of cisplatin- and oxaliplatin-DNA adducts

This publication has 92 references indexed in Scilit:

• NMR Solution Structure of an Oxaliplatin 1,2-d(GG) Intrastrand Cross-link in a DNA Dodecamer Duplex
  Journal of Molecular Biology, 2004
• Two-step error-prone bypass of the (+)- and (−)-trans-anti-BPDE-N2-dG adducts by human DNA polymerases η and κ
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2002
• A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer
  Oncogene, 1999
• NMR Solution Structure of a DNA Dodecamer Duplex Containing a cis-Diammineplatinum(II) d(GpG) Intrastrand Cross-Link, the Major Adduct of the Anticancer Drug Cisplatin
  Biochemistry, 1998
• HMG1 protein inhibits the translesion synthesis of the major DNA cisplatin adduct by cell extracts 1 1Edited by M. Yaniv
  Journal of Molecular Biology, 1997
• Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel
  Biochemical Pharmacology, 1996
• Binding of Ixr1, a Yeast HMG-Domain Protein, to Cisplatin−DNA Adducts in Vitro and in Vivo
  Biochemistry, 1996
• Mutations recovered in the Chinese hamster aprt gene after exposure to carboplatin: a comparison with cisplatin
  Carcinogenesis: Integrative Cancer Research, 1992
• Spectrum ofcis-diamminedichloroplatinum(II)-induced mutations in a shuttle vector propagated in human cells
  Molecular Carcinogenesis, 1991
• Characterization of adducts produced in DNA by isomeric 1,2-diaminocyclohexaneplatinum(II) complexes
  Chemico-Biological Interactions, 1989